Combretastatin A4 phosphate: a novel vascular disrupting agent

By Nagaiah Govardhanan   Remick Scot C  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1219-1228

Future Medicine

Access to resources Recommend Favorite

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

By Breidahl Tomas   Nielsen Flemming   Stødkilde-Jørgensen Hans   Maxwell Ross   Horsman Michael  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 306-316

Informa Healthcare

Access to resources Recommend Favorite

Activity of the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate in a Xenograft Model of AIDS-Associated Kaposi's Sarcoma

By Rojiani Amyn M.   Li Lingyun   Rise Leroy   Siemann Dietmar W.  

Acta Oncologica, Vol. 41, Iss. 1, 2002-02 ,pp. : 98-105

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Evaluations of Therapies Combining the Vascular Targeting Agent Combretastatin A-4 Disodium Phosphate and Conventional Anticancer Therapies in the Treatment of Kaposi's Sarcoma

By Li Lingyun   Rojiani Amyn M.   Siemann Dietmar W.  

Acta Oncologica, Vol. 41, Iss. 1, 2002-02 ,pp. : 91-97

Informa Healthcare

Access to resources Recommend Favorite

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Radiation Biology, Vol. 77, Iss. 2, 2001-02 ,pp. : 195-204

Informa Healthcare

Access to resources Recommend Favorite